APA

Sathyapalan T., Dakroury Y., Ahmed L., Elshewehy A. M. M., Kilpatrick E. S., Coady A. & Atkin S. L. (20180925). Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome. : Clinical endocrinology.

Chicago

Sathyapalan Thozhukat, Dakroury Youssra, Ahmed Lina, Elshewehy Abeer M M, Kilpatrick Eric S, Coady Anne-Marie and Atkin Stephen L. 20180925. Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome. : Clinical endocrinology.

Harvard

Sathyapalan T., Dakroury Y., Ahmed L., Elshewehy A. M. M., Kilpatrick E. S., Coady A. and Atkin S. L. (20180925). Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome. : Clinical endocrinology.

MLA

Sathyapalan Thozhukat, Dakroury Youssra, Ahmed Lina, Elshewehy Abeer M M, Kilpatrick Eric S, Coady Anne-Marie and Atkin Stephen L. Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome. : Clinical endocrinology. 20180925.